Package Leaflet: Information for the Patient
Jardiance 10mg film-coated tablets
Jardiance 25mg film-coated tablets
empagliflozin
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is Jardiance
Jardiance contains the active substance empagliflozin.
Jardiance is a member of a group of medicines called sodium-glucose cotransporter 2 (SGLT2) inhibitors.
What is Jardiance used for
Type 2 diabetes mellitus
Jardiance works by blocking a protein in the kidneys called SGLT2. This causes the removal of sugar (glucose) from the blood into the urine. In this way, Jardiance reduces the amount of sugar in the blood.
This medicine may also help prevent heart disease in patients with type 2 diabetes mellitus.
It is important that you follow the diet and exercise plan recommended by your doctor, pharmacist, or nurse while taking Jardiance.
Heart failure
Chronic kidney disease
What is type 2 diabetes?
Type 2 diabetes is a disease that comes from your genes and lifestyle. If you have type 2 diabetes, your pancreas does not produce enough insulin to control the level of glucose in your blood, and your body is unable to use its own insulin effectively. This leads to high levels of glucose in your blood, which can cause medical problems such as heart disease, kidney disease, blindness, and poor circulation in your limbs.
What is heart failure?
Heart failure occurs when the heart is too weak or stiff and cannot work properly. This can cause serious medical problems and require hospital care. The most common symptoms of heart failure are shortness of breath (dyspnea), feeling tired or very tired, and swelling of the ankles.
Jardiance helps protect your heart from increased weakness and improves symptoms.
What is chronic kidney disease?
Chronic kidney disease is a long-term disorder. It could be caused by other diseases such as diabetes and high blood pressure or even by the patient's own immune system attacking the kidneys. When you have chronic kidney disease, your kidneys may progressively lose their ability to clean and filter your blood properly. This can cause serious medical problems such as swollen legs, heart failure, or the need for hospital care.
Jardiance helps protect your kidneys from losing their function.
Do not take Jardiance
Warnings and precautions
Contact a doctor or the nearest hospital immediately:
Ketoacidosis
If you suspect you have ketoacidosis, contact a doctor or the nearest hospital immediately and stop taking this medicine until you talk to your doctor.
Consult your doctor, pharmacist, or nurse before starting and during treatment with this medicine:
Possible signs include those listed in section 4 under "dehydration". Your doctor may ask you to stop taking Jardiance until you recover to prevent excessive fluid loss. Ask your doctor how to prevent dehydration.
Consult your doctor immediately if you experience a combination of symptoms of pain, tenderness, redness, or swelling of the genitals or the area between the genitals and the anus, with fever or general discomfort. These symptoms could be a sign of a rare but serious and potentially life-threatening infection called necrotizing fasciitis of the perineum or Fournier's gangrene, which destroys tissue under the skin. Fournier's gangrene should be treated immediately.
Foot care
As with all diabetic patients, it is important that you regularly check your feet and follow all foot care advice provided by your healthcare professional.
Kidney function
Your kidney function should be checked before you start taking this medicine and during treatment with it.
Glucose in urine
Due to the way this medicine works, your urine will test positive for glucose while you are taking this medicine.
Children and adolescents
Jardiance can be used in children aged 10 years and older for the treatment of type 2 diabetes. There is no data available in children under 10 years of age.
Jardiance is not recommended in children and adolescents under 18 years of age for the treatment of heart failure or for the treatment of chronic kidney disease, as it has not been studied in these patients.
Other medicines and Jardiance
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
It is particularly important that you inform your doctor in the following cases:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Do not use Jardiance if you are pregnant. It is not known if Jardiance is harmful to the fetus. Do not use Jardiance if you are breastfeeding. It is not known if Jardiance passes into breast milk.
Driving and using machines
Jardiance has a minor influence on the ability to drive and use machines.
Taking this medicine in combination with medicines called sulfonylureas or with insulin may cause your blood glucose levels to become too low (hypoglycemia), which can cause symptoms such as trembling, sweating, and changes in vision that can affect your ability to drive and use machines. Do not drive or use tools or machines if you feel dizzy while taking Jardiance.
Jardiance contains lactose
Jardiance contains lactose (milk sugar). If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Jardiance contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, consult your doctor or pharmacist again.
How much to take
How to take this medicine
If you have type 2 diabetes mellitus, your doctor may prescribe Jardiance along with another medicine for diabetes. Remember to take all your medicines as directed by your doctor to get the best results for your health.
A suitable diet and exercise help your body make better use of the glucose in your blood. It is important to follow the diet and exercise plan recommended by your doctor, pharmacist, or nurse while taking Jardiance.
If you take more Jardiance than you should
If you take more Jardiance than you should, consult a doctor immediately or go to the hospital. Take the medicine pack with you.
If you forget to take Jardiance
If you forget to take a tablet, what you should do depends on how much time is left until your next dose.
If you stop taking Jardiance
Do not stop taking Jardiance without consulting your doctor first, unless you suspect you have ketoacidosis (see "Ketoacidosis" in "Warnings and precautions"). If you have type 2 diabetes mellitus, your blood glucose levels may increase if you stop taking Jardiance.
If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact a doctor or the nearest hospital immediately if you have any of the following side effects:
Severe allergic reaction, observed rarely (may affect up to 1 in 100 people)
Possible signs of a severe allergic reaction may include:
Ketoacidosis, observed rarely (may affect up to 1 in 100 people)
These are the signs of ketoacidosis (see also section 2 "Warnings and precautions"):
This can occur regardless of your blood glucose level. Your doctor may decide to temporarily or permanently stop treatment with Jardiance.
Contact your doctor as soon as possible if you experience the following side effects:
Low blood glucose levels (hypoglycemia), observed very frequently (may affect more than 1 in 10 people)
If you take Jardiance with another medicine that can cause low blood glucose levels, such as a sulfonylurea or insulin, the risk of having low blood glucose levels is higher. Signs of low blood glucose levels include:
Your doctor will tell you how to treat low blood glucose levels and what to do if you have any of the above signs. If you have symptoms of low blood glucose levels, take glucose tablets, have a snack with a high glucose content, or drink a fruit juice.
Measure your glucose levels if possible and rest.
Urinary tract infection, observed frequently (may affect up to 1 in 10 people)
Signs of a urinary tract infection are:
The need to urinate urgently or more frequently may be due to the way Jardiance works, but it can also be a sign of a urinary tract infection. If you experience an increase in these symptoms, contact your doctor.
Dehydration, observed very frequently (may affect more than 1 in 10 people)
Signs of dehydration are not specific, but may include:
Other side effects while taking Jardiance:
Frequent
Uncommon
Rare
Very rare
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after "EXP". The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Jardiance Composition
Product Appearance and Package Contents
Jardiance 10 mg film-coated tablets are round, pale yellow, biconvex, and have a beveled edge. They are engraved with the inscription «S10» on one side and the Boehringer Ingelheim logo on the other. The tablets measure 9.1 mm in diameter.
Jardiance 25 mg film-coated tablets are oval, pale yellow, and biconvex. They are engraved with the inscription «S25» on one side and the Boehringer Ingelheim logo on the other. The tablet measures 11.1 mm in length and 5.6 mm in width.
Jardiance tablets are available in single-dose perforated PVC/aluminum blisters. The package sizes are 7 x 1, 10 x 1, 14 x 1, 28 x 1, 30 x 1, 60 x 1, 70 x 1, 90 x 1, and 100 x 1 film-coated tablets.
Only some package sizes may be marketed in your country.
Marketing Authorization Holder
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein
Germany
Manufacturer
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein
Germany
Boehringer Ingelheim Hellas Single Member S.A.
5th km Paiania – Markopoulo
Koropi Attiki, 19441
Greece
Rottendorf Pharma GmbH
Ostenfelder Strasse 51 – 61
59320 Ennigerloh
Germany
Boehringer Ingelheim France
100-104 Avenue de France
75013 Paris
France
You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien Boehringer Ingelheim SComm Tél/Tel: +32 2 773 33 11 | Lietuva Boehringer Ingelheim RCV GmbH & Co KG Lietuvos filialas Tel.: +370 5 2595942 |
Luxembourg/Luxemburg Boehringer Ingelheim SComm Tél/Tel: +32 2 773 33 11 | |
Ceská republika Boehringer Ingelheim spol. s r.o. Tel: +420 234 655 111 | Magyarország Boehringer Ingelheim RCV GmbH & Co KG Magyarországi Fióktelepe Tel.: +36 1 299 89 00 |
Danmark Boehringer Ingelheim Danmark A/S Tlf: +45 39 15 88 88 | Malta Boehringer Ingelheim Ireland Ltd. Tel: +353 1 295 9620 |
Deutschland Boehringer Ingelheim Pharma GmbH & Co. KG Tel: +49 (0) 800 77 90 900 | Nederland Boehringer Ingelheim B.V. Tel: +31 (0) 800 22 55 889 |
Eesti Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal Tel: +372 612 8000 | Norge Boehringer Ingelheim Danmark Norwegian branch Tlf: +47 66 76 13 00 |
Ελλάδα Boehringer Ingelheim Ελλάς Μονοπρόσωπη A.E. Tηλ: +30 2 10 89 06 300 | Österreich Boehringer Ingelheim RCV GmbH & Co KG Tel: +43 1 80 105-7870 |
España Boehringer Ingelheim España, S.A. Tel: +34 93 404 51 00 | Polska Boehringer Ingelheim Sp.zo.o. Tel.: +48 22 699 0 699 |
France Boehringer Ingelheim France S.A.S. Tél: +33 3 26 50 45 33 | Portugal Boehringer Ingelheim Portugal, Lda. Tel: +351 21 313 53 00 |
Hrvatska Boehringer Ingelheim Zagreb d.o.o. Tel: +385 1 2444 600 | România Boehringer Ingelheim RCV GmbH & Co KG Viena - Sucursala Bucuresti Tel: +40 21 302 28 00 |
Ireland Boehringer Ingelheim Ireland Ltd. Tel: +353 1 295 9620 | Slovenija Boehringer Ingelheim RCV GmbH & Co KG Podružnica Ljubljana Tel: +386 1 586 40 00 |
Ísland Vistor ehf. Sími: +354 535 7000 | Slovenská republika Boehringer Ingelheim RCV GmbH & Co KG organizacná zložka Tel: +421 2 5810 1211 |
Italia Boehringer Ingelheim Italia S.p.A. Tel: +39 02 5355 1 | Suomi/Finland Boehringer Ingelheim Finland Ky Puh/Tel: +358 10 3102 800 |
Κύπρος Boehringer Ingelheim Ελλάς Μονοπρόσωπη A.E. Tηλ: +30 2 10 89 06 300 | Sverige Boehringer Ingelheim AB Tel: +46 8 721 21 00 |
Latvija Boehringer Ingelheim RCV GmbH & Co KG Latvijas filiale Tel: +371 67 240 011 | United Kingdom (Northern Ireland) Boehringer Ingelheim Ireland Ltd. Tel: +353 1 295 9620 |
Date of the last revision of this leaflet: {MM/AAAA}.
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.
The average price of JARDIANCE 10 mg FILM-COATED TABLETS in October, 2025 is around 49.31 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.